BusinessContraFect to Present at the 20th Annual Superbugs & Superdrugs UK ConferenceBy Nasdaq OMXMar 14, 2018, 11:00 AM UTC
BusinessAvivagen Announces Presentation at the Bloom Burton & Co. Healthcare Investor Conference on May 2, 2017By Nasdaq OMXApr 26, 2017, 7:28 PM UTC
BusinessAvivagen Announces Results From Its Annual and Special Meeting of ShareholdersBy Nasdaq OMXApr 12, 2017, 1:27 PM UTC
BusinessAvivagen Reports Positive Proof of Concept in Preventing C. Difficile InfectionBy Nasdaq OMXApr 10, 2017, 11:43 AM UTC
